
Freya Biosciences reports positive data on IVF therapeutic
Immunology company Freya Biosciences has reported positive Phase I results for its treatment for IVF-related embryo implantation failure. FB301, a defined multi-strain Lactobacillus consortium developed using Freya’s Dyscover platform, was safe and well tolerated in healthy female subjects, with all primary and secondary endpoints met. The trial was a… Read More

